Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation

Curative treatment options for patients with early stage hepatocellular carcinoma (HCC) include resection, liver transplantation, and percutaneous ablation therapy. However, even patients with solitary HCC are not always amenable to these treatments. The authors prospectively investigated the clinical outcomes of patients who received stereotactic body radiotherapy (SBRT) for solitary HCC.

[1]  Mary Feng,et al.  Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  J. Salleron,et al.  Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  K. Awai,et al.  Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[4]  H. Moon,et al.  Risk factors and therapeutic results of early local recurrence after transcatheter arterial chemoembolization. , 2014, World journal of gastroenterology.

[5]  M. Choti,et al.  Surgical Therapy for Early Hepatocellular Carcinoma in the Modern Era: A 10-Year SEER-Medicare Analysis , 2013, Annals of surgery.

[6]  Zahra Kassam,et al.  Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  E. Kunieda,et al.  Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system. , 2013, International journal of radiation oncology, biology, physics.

[8]  Dong Han Lee,et al.  Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization , 2012, Cancer.

[9]  J. Schwartz,et al.  Liver transplantation in septuagenarians receiving model for end‐stage liver disease exception points for hepatocellular carcinoma: The national experience , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[10]  A. Hezel,et al.  Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlation. , 2012, International journal of radiation oncology, biology, physics.

[11]  Sheng-Nan Lu,et al.  Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. , 2012, Journal of hepatology.

[12]  Cynthia S. Johnson,et al.  Stereotactic body radiotherapy for primary hepatocellular carcinoma. , 2011, International journal of radiation oncology, biology, physics.

[13]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[14]  M. Miften,et al.  Radiation-associated liver injury. , 2010, International journal of radiation oncology, biology, physics.

[15]  Yun Yen,et al.  NCCN clinical practice guidelines in oncology: hepatobiliary cancers. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[16]  E. Kunieda,et al.  Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: Preliminary results for efficacy and toxicity , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[17]  Luigi Solbiati,et al.  Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? , 2007, Hepatology.

[18]  K. Hayashi,et al.  Local Therapeutic Results of Computed Tomography-Guided Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Results of 265 Tumors in 79 Patients , 2007, CardioVascular and Interventional Radiology.

[19]  S-M. Lin,et al.  Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less , 2005, Gut.

[20]  Steven S Raman,et al.  Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. , 2005, Radiology.

[21]  Carlo Bartolozzi,et al.  Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. , 2003, Radiology.

[22]  T. Arima,et al.  Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation , 2003, Cancer.

[23]  O. Farges,et al.  Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. , 2002, Surgery.

[24]  Sergi Ganau,et al.  Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma , 2001, Hepatology.

[25]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[26]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[27]  G. Práctica,et al.  European Association for the Study of the Liver , 1971 .